Works about COLON cancer treatment

Results: 4516

Vitamin D as a promising anticancer agent.

Published in:

Indian Journal of Pharmacology, 2011, v. 43, n. 2, p. 113, doi. 10.4103/0253-7613.77335

By:

Chakraborti, Chandra Kanti

Publication type:

Article

Symptomatic and Asymptomatic Colon Cancer Recurrence: A Multicenter Cohort Study.

Published in:

2016

By:

Duineveld, Laura A. M.;
van Asselt, Kristel M.;
Bemelman, Willem A.;
Smits, Anke B.;
Tanis, Pieter J.;
van Weert, Henk C. P. M.;
Wind, Jan

Publication type:

journal article

Can aspirin prevent hereditary colon cancer?

Published in:: Patient Care (Print), 1998, v. 32, n. 19, p. 8
Publication type:: Article

Latest approaches to prevention and screening.

Published in:

Patient Care (Print), 1996, v. 30, n. 7, p. 124

By:

Dominitz, Jason A.;
McCormick, Louis H.

Publication type:

Article

Novel biotechnology approaches in colorectal cancer diagnosis and therapy.

Published in:

Biotechnology Letters, 2017, v. 39, n. 6, p. 785, doi. 10.1007/s10529-017-2303-8

By:

Kavousipour, Soudabeh;
Khademi, Fathemeh;
Zamani, Mozhdeh;
Vakili, Bahareh;
Mokarram, Pooneh

Publication type:

Article

Treating colon cancer with injectable PLGA-PEG-PLGA as a carrier for iodine-125.

Published in:

Biotechnology Letters, 2013, v. 35, n. 12, p. 2005, doi. 10.1007/s10529-013-1308-1

By:

Ma, Zhenhuan;
Luo, Kaiyuan;
Yang, Yong;
Yang, Guokai;
Wan, Jia;
Li, Guojian

Publication type:

Article

Liver transplantation for colorectal liver metastases: revisiting the concept.

Published in:

Transplant International, 2010, v. 23, n. 7, p. 679, doi. 10.1111/j.1432-2277.2010.01097.x

By:

Foss, Aksel;
Adam, Rene;
Dueland, Svein

Publication type:

Article

Congenital infantile fibrosarcoma of the colon: a case series and literature review.

Published in:

2014

By:

Parmar, Vijal;
Peters, R.;
Cheesman, E.;
Edi-Osagie, N.;
Craigie, R.

Publication type:

Report

Botulinum toxin use in paediatric colorectal surgery.

Published in:

Pediatric Surgery International, 2014, v. 30, n. 8, p. 833, doi. 10.1007/s00383-014-3536-4

By:

Basson, S.;
Charlesworth, P.;
Healy, C.;
Phelps, S.;
Cleeve, Stewart

Publication type:

Article

Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 807, doi. 10.1007/s00280-011-1764-z

By:

Mazard, T.;
Ychou, M.;
Thezenas, S.;
Poujol, S.;
Pinguet, F.;
Thirion, A.;
Bleuse, J.;
Portales, F.;
Samalin, E.;
Assenat, E.

Publication type:

Article

A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 743, doi. 10.1007/s00280-011-1762-1

By:

Fakih, M.;
Groman, A.;
McMahon, J.;
Wilding, G.;
Muindi, J.

Publication type:

Article

Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 3, p. 665, doi. 10.1007/s00280-011-1744-3

By:

King, C.;
Ramachandran, S.;
Chaney, S.;
Collins, L.;
Swenberg, J.;
deKrafft, K.;
Lin, W.;
Cicurel, L.;
Barbier, M.

Publication type:

Article

Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 301, doi. 10.1007/s00280-011-1700-2

By:

Afzal, Shoaib;
Jensen, Søren;
Sørensen, Jens;
Henriksen, Trine;
Weimann, Allan;
Poulsen, Henrik

Publication type:

Article

5-Fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 57, doi. 10.1007/s00280-011-1669-x

By:

Jensen, Søren;
Sørensen, Jens

Publication type:

Article

Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 91, doi. 10.1007/s00280-011-1668-y

By:

Kim, Se;
Shin, Sang;
Kim, Sun;
Lee, Se;
Park, Young;
Park, Se;
Lee, Kyung;
Kim, Tae;
Hong, Yong;
Ahn, Joong

Publication type:

Article

Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1449, doi. 10.1007/s00280-011-1641-9

By:

Xavier, Cristina;
Lima, Cristovao;
Rohde, Mikkel;
Pereira-Wilson, Cristina

Publication type:

Article

A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1199, doi. 10.1007/s00280-011-1606-z

By:

Zhi, Jianguo;
Chen, Eric;
Major, Pierre;
Burns, Ivon;
Robinson, Bridget;
McKendrick, Joe;
Rittweger, Karen;
Abt, Markus;
Goldstein, David

Publication type:

Article

Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1207, doi. 10.1007/s00280-011-1604-1

By:

De Stefano, Alfonso;
Carlomagno, Chiara;
Pepe, Stefano;
Bianco, Roberto;
De Placido, Sabino

Publication type:

Article

Phase II study of FOLFOX4 with 'wait and go' strategy as first-line treatment for metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1215, doi. 10.1007/s00280-011-1605-0

By:

Kochi, Mitsugu;
Ichikawa, Wataru;
Meguro, Eiji;
Shibata, Hiroyuki;
Fukui, Takuji;
Nagase, Michitaka;
Hoshino, Yutaka;
Takeuchi, Masahiro;
Fujii, Masashi;
Nakajima, Toshifusa

Publication type:

Article

Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1305, doi. 10.1007/s00280-011-1610-3

By:

Cézé, N.;
Thibault, G.;
Goujon, G.;
Viguier, J.;
Watier, H.;
Dorval, E.;
Lecomte, T.

Publication type:

Article

A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 905, doi. 10.1007/s00280-011-1562-7

By:

Choi, Yoon;
Kim, Tae;
Lee, Sung;
Hong, Yong;
Ryu, Min-Hee;
Lee, Jae-Lyun;
Chang, Heung;
Kang, Yoon-Koo

Publication type:

Article

Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 1045, doi. 10.1007/s00280-011-1586-z

By:

Park, Jin;
Han, Sae-Won;
Oh, Do-Youn;
Im, Seock-Ah;
Jeong, Seung-Yong;
Park, Kyu;
Kim, Tae-You;
Bang, Yung-Jue;
Park, Jae-Gahb

Publication type:

Article

Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 3, p. 763, doi. 10.1007/s00280-010-1543-2

By:

Matsusaka, Satoshi;
Suenaga, Mitsukuni;
Mishima, Yuji;
Takagi, Koichi;
Terui, Yasuhito;
Mizunuma, Nobuyuki;
Hatake, Kiyohiko

Publication type:

Article

Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 547, doi. 10.1007/s00280-011-1620-1

By:

Boasberg, Peter;
Redfern, Charles;
Daniels, Gregory;
Bodkin, David;
Garrett, Chris;
Ricart, Alejandro

Publication type:

Article

UGT1A11/28 and 1/ 6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 279, doi. 10.1007/s00280-010-1485-8

By:

Sunakawa, Yu;
Ichikawa, Wataru;
Fujita, Ken-ichi;
Nagashima, Fumio;
Ishida, Hiroo;
Yamashita, Keishi;
Mizuno, Keiko;
Miwa, Keisuke;
Kawara, Kaori;
Akiyama, Yuko;
Araki, Kazuhiro;
Yamamoto, Wataru;
Miya, Toshimichi;
Narabayashi, Masaru;
Ando, Yuichi;
Hirose, Takashi;
Saji, Shigehira;
Sasaki, Yasutsuna

Publication type:

Article

Clinical impact of K- ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 317, doi. 10.1007/s00280-010-1496-5

By:

Chang, Myung;
Lee, In;
Si, Yoon;
Lee, Kyu;
Woo, In-Sook;
Byun, Jae

Publication type:

Article

The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 389, doi. 10.1007/s00280-010-1495-6

By:

Na, Young-Soon;
Jung, Kyung-Ah;
Kim, Seung-Mi;
Hong, Yong;
Ryu, Min-Hee;
Jang, Se;
Moon, Dae;
Cho, Dong-Hyung;
Kim, Jin;
Lee, Jung;
Kim, Tae

Publication type:

Article

Can localised F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response?

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 29, doi. 10.1007/s00280-010-1438-2

By:

McIntyre, Dominick;
Howe, Franklyn;
Ladroue, Christophe;
Lofts, Fiona;
Stubbs, Marion;
Griffiths, John

Publication type:

Article

Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 263, doi. 10.1007/s00280-011-1633-9

By:

Horimatsu, Takahiro;
Miyamoto, Shin'ichi;
Morita, Shuko;
Mashimo, Yoko;
Ezoe, Yasumasa;
Muto, Manabu;
Chiba, Tsutomu

Publication type:

Article

Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1299, doi. 10.1007/s00280-010-1428-4

By:

Kalimutho, Murugan;
Minutolo, Antonella;
Grelli, Sandro;
Formosa, Amanda;
Sancesario, Giulia;
Valentini, Alessandra;
Federici, Giorgio;
Bernardini, Sergio

Publication type:

Article

Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1323, doi. 10.1007/s00280-010-1425-7

By:

Hong, Junshik;
Han, Sae-Won;
Ham, Hye;
Kim, Tae-Yong;
Choi, In;
Kim, Byung-Su;
Oh, Do-Youn;
Im, Seock-Ah;
Kang, Gyeong;
Bang, Yung-Jue;
Kim, Tae-You

Publication type:

Article

Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 963, doi. 10.1007/s00280-010-1476-9

By:

Garg, Madhu;
Ackland, Stephen

Publication type:

Article

Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 729, doi. 10.1007/s00280-011-1583-2

By:

Shimoyama, Shouji

Publication type:

Article

Plasma disposition of capecitabine and its metabolites 5′DFCR and 5′DFUR in a standard and dose-intensified monotherapy regimen.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 3, p. 613, doi. 10.1007/s00280-010-1363-4

By:

Czejka, Martin;
Schueller, J.;
Farkouh, A.;
Gruenberger, B.;
Scheithauer, W.

Publication type:

Article

Pharmacokinetics in mice and metabolism in murine and human liver fractions of the putative cancer chemopreventive agents 3′,4′,5′,5,7-pentamethoxyflavone and tricin (4′,5,7-trihydroxy-3′,5′-dimethoxyflavone).

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 255, doi. 10.1007/s00280-010-1313-1

By:

Cai, Hong;
Sale, Stewart;
Britton, Robert;
Brown, Karen;
Steward, William;
Gescher, Andreas

Publication type:

Article

Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 369, doi. 10.1007/s00280-010-1335-8

By:

Colombo, Valentina;
Lupi, Monica;
Falcetta, Francesca;
Forestieri, Daniele;
D'Incalci, Maurizio;
Ubezio, Paolo

Publication type:

Article

Molecular determinants of folate levels after leucovorin administration in colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 4, p. 735, doi. 10.1007/s00280-009-1079-5

By:

Sadahiro, Sotaro;
Suzuki, Toshiyuki;
Maeda, Yuji;
Tanaka, Akira;
Ogoshi, Kyoji;
Kamijo, Akemi;
Murayama, Chieko;
Tsukioka, Sayaka;
Sakamoto, Etsuko;
Fukui, Yousuke;
Oka, Toshinori

Publication type:

Article

Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 391, doi. 10.1007/s00280-008-0886-4

By:

Tsavaris, Nicolas;
Lazaris, Andreas;
Kosmas, Christos;
Gouveris, Panagiotis;
Kavantzas, Nikolaos;
Kopterides, Petros;
Papathomas, Thomas;
Arapogiannis, George;
Zorzos, Haralambos;
Kyriakou, Vassiliki;
Patsouris, Efstathios

Publication type:

Article

Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 307, doi. 10.1007/s00280-008-0872-x

By:

Connolly, Kate;
Mitter, Richard;
Muir, Morwenna;
Jodrell, Duncan;
Guichard, Sylvie

Publication type:

Article

Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 3, p. 383, doi. 10.1007/s00280-006-0372-9

By:

Duffour, Jacqueline;
Gourgou, Sophie;
Desseigne, Françoise;
Debrigode, Charles;
Mineur, Laurent;
Pinguet, Frédéric;
Poujol, Sylvain;
Chalbos, Patrick;
Bressole, Françoise;
Ychou, Marc

Publication type:

Article

A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 4, p. 549, doi. 10.1007/s00280-006-0297-3

By:

Shibata, Stephen;
Chow, Warren;
Frankel, Paul;
Juhasz, Agnes;
Leong, Lucille;
Lim, Dean;
Margolin, Kim;
Morgan, Robert;
Newman, Edward;
Somlo, George;
Yen, Yun;
Synold, Timothy;
Gandara, David;
Lenz, Heinz-Josef;
Doroshow, James

Publication type:

Article

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 481, doi. 10.1007/s00280-005-1003-6

By:

Comella, P.;
Massidda, B.;
Palmeri, S.;
Farris, A.;
De Lucia, L.;
Natale, D.;
Maiorino, L.;
Tafuto, S.;
De Cataldis, G.;
Casaretti, R.

Publication type:

Article

Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 1, p. 12, doi. 10.1007/s00280-004-0846-6

By:

Calviello, Gabriella;
Di Nicuolo, Fiorella;
Serini, Simona;
Piccioni, Elisabetta;
Boninsegna, Alma;
Maggiano, Nicola;
Ranelletti, Franco;
Palozza, Paola

Publication type:

Article

Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 6, p. 531, doi. 10.1007/s00280-004-0802-5

By:

Tsuji, Takashi;
Sawai, Terumitsu;
Takeshita, Hiroaki;
Nakagoe, Tohru;
Hidaka, Shigekazu;
Yamaguchi, Hiroyuki;
Yasutake, Toru;
Nagayasu, Takeshi;
Tagawa, Yutaka

Publication type:

Article

Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells.

Published in:

Amino Acids, 2016, v. 48, n. 11, p. 2549, doi. 10.1007/s00726-016-2278-0

By:

Bruns, Helge;
Kazanavicius, Darius;
Schultze, Daniel;
Saeedi, Mohammed;
Yamanaka, Kenia;
Strupas, Kestutis;
Schemmer, Peter

Publication type:

Article

Ac- tLeu-Asp-H is the minimal and highly effective human caspase-3 inhibitor: biological and in silico studies.

Published in:

Amino Acids, 2015, v. 47, n. 1, p. 153, doi. 10.1007/s00726-014-1855-3

By:

Ferrucci, Anna;
Leboffe, Loris;
Agamennone, Mariangela;
Di Pizio, Antonella;
Fiocchetti, Marco;
Marino, Maria;
Ascenzi, Paolo;
Luisi, Grazia

Publication type:

Article

Kynurenic acid inhibits colon cancer proliferation in vitro: effects on signaling pathways.

Published in:

Amino Acids, 2014, v. 46, n. 10, p. 2393, doi. 10.1007/s00726-014-1790-3

By:

Walczak, Katarzyna;
Turski, Waldemar;
Rajtar, Grażyna

Publication type:

Article

Prolonged Survival of Patients with Metastatic Colorectal Cancer following First-Line Oxaliplatin-Based Chemotherapy with Molecular Targeting Agents and Curative Surgery.

Published in:

Oncology, 2011, v. 81, n. 3/4, p. 167, doi. 10.1159/000333404

By:

Shitara, Kohei;
Matsuo, Keitaro;
Kondo, Chihiro;
Takahari, Daisuke;
Ura, Takashi;
Inaba, Yoshitaka;
Yamaura, Hidekazu;
Sato, Yozo;
Kato, Mina;
Kanemitsu, Yukihide;
Komori, Koji;
Ishiguro, Seiji;
Sano, Tsuyoshi;
Shimizu, Yasuhiro;
Muro, Kei

Publication type:

Article

Cost-Minimisation Analysis in First-Line Treatment of Metastatic Colorectal Cancer in France: XELOX versus FOLFOX-6.

Published in:

Oncology, 2011, v. 79, n. 3/4, p. 174, doi. 10.1159/000325999

By:

Perrocheau, G.;
Bennouna, J.;
Ducreux, M.;
Hebbar, M.;
Ychou, M.;
Lledo, G.;
Conroy, T.;
Dominguez, S.;
Faroux, R.;
Florentin, V.;
Douillard, J. Y.

Publication type:

Article

Immunological Effects of Bevacizumab-Based Treatment in Metastatic Colorectal Cancer.

Published in:

Oncology, 2011, v. 79, n. 3/4, p. 187, doi. 10.1159/000320609

By:

Manzoni, M.;
Rovati, B.;
Ronzoni, M.;
Loupakis, F.;
Mariucci, S.;
Ricci, V.;
Gattoni, E.;
Salvatore, L.;
Tinelli, C.;
Villa, E.;
Danova, M.

Publication type:

Article